{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "collapsed_sections": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "NukY3cbNot5l"
      },
      "outputs": [],
      "source": [
        "\"\"\"\n",
        "Momento de Retroalimentación: Módulo 3 NLP Module Project.\n",
        "(Implemantation Portafolio )\n",
        "\n",
        "Fecha Inicio del Trabajo:  27/08/2022\n",
        "\n",
        "Fecha de Finalizado: 12/11/2022\n",
        "\n",
        "\n",
        "Nombre: Roberto Valdez\n",
        "\n",
        "Matricula: A01746863\n",
        "\n",
        "\n",
        "Introductions:\n",
        "\n",
        "This homework is designed to give you a glimpse of \n",
        "what it’s like to be an NLP-focused software developer \n",
        "in industry.  All of these are realistic tasks, \n",
        "loosely based upon work I have done for real companies! \n",
        "\n",
        "\n",
        "Please write your own code. I will read all code,\n",
        "and if two students’ code is suspiciously similar \n",
        "(i.e. obviously copied from another),\n",
        "it will result in a 0 score for all involved parties. \n",
        "It is okay to discuss the project and approaches at a \n",
        "high level with your classmates, but it is not okay \n",
        "to copy-paste code from a friend.\n",
        "\n",
        "Evaluation Metrics link: \n",
        "https://experiencia21.tec.mx/courses/315342/assignments/9856676\n",
        "\n",
        "\n",
        "Tasks: \n",
        "\n",
        "2. NER: Take a basic, pretrained NER model, and train \n",
        "further on a task-specific dataset\n",
        "\n",
        " * Start from Huggingface basic NER, then set up a trainer to further train\n",
        " * This is probably the hardest part of the homework, so start early! \n",
        " * Example datasets: \n",
        "    * Twitter_dataset\n",
        "    * Medical_dataset\n",
        "  * You can use any other dataset – you choose! \n",
        "  Any of the models from here.\n",
        "  will be nicer for you, because you can use \n",
        "  huggingface’s load_dataset method to do the dataloading for you.\n",
        " \n",
        "\n",
        "  * Suggestion: create a ModelTrainer class that loads the dataset,\n",
        "  loads the base model, and trains. \n",
        "  (ModelTrainer could have smaller helper classes \n",
        "  that you write as well!) and then do something like:\n",
        "  \n",
        "    model_trainer = ModelTrainer()\n",
        "\n",
        "    model_trainer.train()\n",
        "\n",
        " \n",
        "  * Please set a constant in the code called\n",
        "   N_EXAMPLES_TO_TRAIN that limits the training to \n",
        "   that number of examples, so that I can run the code \n",
        "   without waiting for it to run over the entire dataset, if large.\n",
        "  * WHAT TO PRINT:  graph(s) of train set error and \n",
        "  test set error rate during training.\n",
        "  \n",
        "These can be done using pyplotlib, or similar\n",
        " \n",
        "\"\"\""
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "import spacy\n",
        "from spacy import displacy\n",
        "import numpy as np\n",
        "from sklearn import linear_model\n",
        "from sklearn.datasets import make_regression\n",
        "from sklearn.model_selection import train_test_split\n",
        "import matplotlib.pyplot as plt"
      ],
      "metadata": {
        "id": "J8x1lHR1qlOC"
      },
      "execution_count": 42,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "class nlp_Activity_2:\n",
        "  # _init_ method\n",
        "  def __init__(self, jsonFile):\n",
        "     self.jsonFile = jsonFile \n",
        "\n",
        "  def subsets(jsonFile):\n",
        "    with open(jsonFile) as f:\n",
        "      lines = json.load(f)\n",
        "    train, test = train_test_split(lines[\"examples\"], test_size=0.3)\n",
        "    val, test = train_test_split(test, test_size=0.5)\n",
        "    return train, test, val\n",
        "\n",
        "  def model_NER_Training(jsonFile):\n",
        "    train, test, val = nlp_Activity_2.subsets(jsonFile)\n",
        "    NER = spacy.load(\"en_core_web_sm\")\n",
        "    i = 0\n",
        "    for i in range(len(train)):\n",
        "      raw_text = train[i]\n",
        "      #print(raw_text[\"content\"])\n",
        "      text = NER(raw_text[\"content\"])\n",
        "      for word in text.ents:\n",
        "          print(word.text,word.label_)\n",
        "      i += 1\n",
        "\n",
        "  def NER_Display_render(jsonFile):\n",
        "    train, test, val = nlp_Activity_2.subsets(jsonFile)\n",
        "    NER = spacy.load(\"en_core_web_sm\")\n",
        "    i = 0\n",
        "    for i in range(len(train)):\n",
        "      raw_text = train[i]\n",
        "      #print(raw_text[\"content\"])\n",
        "      text = NER(raw_text[\"content\"])\n",
        "    displacy.render(text,style=\"ent\",jupyter=True)\n",
        "    \n"
      ],
      "metadata": {
        "id": "suPHxDdhTCIX"
      },
      "execution_count": 58,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "ner = nlp_Activity_2.model_NER_Training('./Corona2.json')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "EthVgB8hV_aj",
        "outputId": "8d6649ff-1bce-46d2-b2c1-43238ba11ea6"
      },
      "execution_count": 57,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "1982–1995 CARDINAL\n",
            "about 2 million CARDINAL\n",
            "Streptococcus and Pseudomonas ORG\n",
            "Shigella ORG\n",
            "Salmonella ORG\n",
            "Hansen ORG\n",
            "between 1 and 5 CARDINAL\n",
            "infliximab ORG\n",
            "Rituximab PERSON\n",
            "Hydroxychloroquine PRODUCT\n",
            "RA ORG\n",
            "6–12 months DATE\n",
            "2 years.[89 DATE\n",
            "Sulfasalazine ORG\n",
            "Sodium ORG\n",
            "RA ORG\n",
            "effects.[8][92] LOC\n",
            "DMARD ORG\n",
            "first ORDINAL\n",
            "HAQ ORG\n",
            "RA ORG\n",
            "Gabapentin GPE\n",
            "neuralgia GPE\n",
            "disorder1 ORG\n",
            "first ORDINAL\n",
            "FDA ORG\n",
            "first ORDINAL\n",
            "One CARDINAL\n",
            "SNRI ORG\n",
            "social phobia ORG\n",
            "five CARDINAL\n",
            "European NORP\n",
            "TCA ORG\n",
            "CR GPE\n",
            "two days DATE\n",
            "more than two CARDINAL\n",
            "24-hour TIME\n",
            "2003 DATE\n",
            "the prior year DATE\n",
            "Asia LOC\n",
            "the World Health Organization ORG\n",
            "More than 8,000 CARDINAL\n",
            "about ten percent PERCENT\n",
            "TB ORG\n",
            "three to nine months DATE\n",
            "TB ORG\n",
            "TB ORG\n",
            "13% PERCENT\n",
            "TB ORG\n",
            "Africa LOC\n",
            "about 5–10% PERCENT\n",
            "30% PERCENT\n",
            "North and South America GPE\n",
            "Western Europe LOC\n",
            "Australia GPE\n",
            "the United States GPE\n",
            "19 CARDINAL\n",
            "1997–2006 CARDINAL\n",
            "17 CARDINAL\n",
            "North America LOC\n",
            "about half CARDINAL\n",
            "two CARDINAL\n",
            "1956 DATE\n",
            "1959 DATE\n",
            "2 CARDINAL\n",
            "ART ORG\n",
            "ART ORG\n",
            "Epstein–Barr PRODUCT\n",
            "at least one CARDINAL\n",
            "Yersinia GPE\n",
            "two CARDINAL\n",
            "Mouyassué PERSON\n",
            "banana pipistrelle ORG\n",
            "Mouyassué GPE\n",
            "Cote d'Ivoire GPE\n",
            "West Africa GPE\n",
            "Magboi PERSON\n",
            "hairy slit-faced PERSON\n",
            "the Magboi River LOC\n",
            "Sierra Leone ORG\n",
            "2011 DATE\n",
            "RNA ORG\n",
            "Bunyaviridae GPE\n",
            "M2 CARDINAL\n",
            "M2 drug target.[160] Measured PRODUCT\n",
            "American NORP\n",
            "91% PERCENT\n",
            "China GPE\n",
            "CDC ORG\n",
            "M2 CARDINAL\n",
            "2005–06 ORDINAL\n",
            "Salmonella GPE\n",
            "Neisseria GPE\n",
            "Brucella, Mycobacterium, ORG\n",
            "Nocardia GPE\n",
            "Listeria GPE\n",
            "Francisella PERSON\n",
            "Legionella PERSON\n",
            "Yersinia GPE\n",
            "Lactobacilli GPE\n",
            "Trichomonas GPE\n",
            "Bacterial ORG\n",
            "Escherichia PERSON\n",
            "Urine PERSON\n",
            "Bacteria PERSON\n",
            "Escherichia NORP\n",
            "Staphylococcus ORG\n",
            "Streptococcus pyogenes.[13]\n",
            "Erysipelas ORG\n",
            "Cellulitis PRODUCT\n",
            "two CARDINAL\n",
            "M2 CARDINAL\n",
            "at least three CARDINAL\n",
            "a few days DATE\n",
            "Zyban ORG\n",
            "Ontario GPE\n",
            "Canada GPE\n",
            "Zyban ORG\n",
            "Wellbutrin GPE\n",
            "Wellbutrin LOC\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "disp = nlp_Activity_2.NER_Display_render('./Corona2.json')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 402
        },
        "id": "lZeCoq9UA-KB",
        "outputId": "5b074e74-3f5a-4e32-8e1d-88c08edc0c08"
      },
      "execution_count": 59,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "<span class=\"tex2jax_ignore\"><div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">The following drugs are considered as DMARDs: methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, TNF-alpha inhibitors (certolizumab, \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    infliximab\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " and etanercept), abatacept, and anakinra. \n",
              "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Rituximab\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
              "</mark>\n",
              " and tocilizumab are monoclonal antibodies and are also DMARDs.[8] Use of tocilizumab is associated with a risk of increased cholesterol levels.[87]</br></br>\n",
              "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Hydroxychloroquine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
              "</mark>\n",
              ", apart from its low toxicity profile, is considered effective in the moderate \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " treatment.[88]</br></br>The most commonly used agent is methotrexate with other frequently used agents including sulfasalazine and leflunomide.[8] Leflunomide is effective when used from \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    6–12 months\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              ", with similar effectiveness to methotrexate when used for \n",
              "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    2 years.[89\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
              "</mark>\n",
              "] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Sulfasalazine\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " also appears to be most effective in the short-term treatment of rheumatoid arthritis.[90] \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    Sodium\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " aurothiomalate (gold) and cyclosporin are less commonly used due to more common adverse effects.[8] However, cyclosporin was found to be effective in the progressive \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " when used up to one year.[91] Agents may be used in combinations however, people may experience greater side \n",
              "<mark class=\"entity\" style=\"background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    effects.[8][92]\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">LOC</span>\n",
              "</mark>\n",
              " Methotrexate is the most important and useful \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    DMARD\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " and is usually the \n",
              "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    first\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORDINAL</span>\n",
              "</mark>\n",
              " treatment.[8][5][93] A combined approach with methotrexate and biologics improves ACR50, \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    HAQ\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " scores and \n",
              "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">\n",
              "    RA\n",
              "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
              "</mark>\n",
              " remission rates.[94] Triple therapy consisting of methotrexate, sulfasalazine and hydroxychloroquine may also effectively control disease activity.[95] Adverse effects should be monitored regularly with toxicity including gastrointestinal, hematologic, pulmonary, and hepatic.[93] Side effects such as nausea, vomiting or abdominal pain can be reduced by taking folic acid.[96]</div></span>"
            ]
          },
          "metadata": {}
        }
      ]
    }
  ]
}